Resveratrol-loaded nanoparticles conjugated with kidney injury molecule-1 as a drug delivery system for potential use in chronic kidney disease
出版年份 2017 全文链接
标题
Resveratrol-loaded nanoparticles conjugated with kidney injury molecule-1 as a drug delivery system for potential use in chronic kidney disease
作者
关键词
-
出版物
Nanomedicine
Volume 12, Issue 22, Pages 2741-2756
出版商
Future Medicine Ltd
发表日期
2017-09-08
DOI
10.2217/nnm-2017-0256
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Atg5-mediated autophagy deficiency in proximal tubules promotes cell cycle G2/M arrest and renal fibrosis
- (2016) Huiyan Li et al. Autophagy
- Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation
- (2016) Lei Jiang et al. BIOMEDICINE & PHARMACOTHERAPY
- Far-infrared promotes burn wound healing by suppressing NLRP3 inflammasome caused by enhanced autophagy
- (2016) Hui-Wen Chiu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The NLRP3 inflammasome in kidney disease and autoimmunity
- (2016) Holly L Hutton et al. NEPHROLOGY
- Sirt1 is essential for resveratrol enhancement of hypoxia-induced autophagy in the type 2 diabetic nephropathy rat
- (2016) Liqun Ma et al. PATHOLOGY RESEARCH AND PRACTICE
- Suppression of NLRP3 Inflammasome Activation Ameliorates Chronic Kidney Disease-Induced Cardiac Fibrosis and Diastolic Dysfunction
- (2016) Antoinette Bugyei-Twum et al. Scientific Reports
- Resveratrol nanoformulations: Challenges and opportunities
- (2015) Natalie Summerlin et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy
- (2015) Ya-Ping Chang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Inflammasomes: mechanism of action, role in disease and therapeutics
- (2015) Haitao Guo et al. NATURE MEDICINE
- Novel targets of antifibrotic and anti-inflammatory treatment in CKD
- (2014) Anne-Emilie Declèves et al. Nature Reviews Nephrology
- Anti-nephrolithic potential of resveratrol via inhibition of ROS, MCP-1, hyaluronan and osteopontin in vitro and in vivo
- (2014) Sang Hyuk Hong et al. Pharmacological Reports
- Bioenergetic Dysfunction and Inflammation in Alzheimer’s Disease: A Possible Connection
- (2014) Heather M. Wilkins et al. Frontiers in Aging Neuroscience
- Autophagic cell death induced by resveratrol depends on the Ca2+/AMPK/mTOR pathway in A549 cells
- (2013) Jun Zhang et al. BIOCHEMICAL PHARMACOLOGY
- Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis
- (2013) Georg Lorenz et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction
- (2013) Jin Liang et al. RENAL FAILURE
- Resveratrol in Medicinal Chemistry: A Critical Review of its Pharmacokinetics, Drug-Delivery, and Membrane Interactions
- (2012) A. R. Neves et al. CURRENT MEDICINAL CHEMISTRY
- Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK–SIRT1–PGC1α axis in db/db mice
- (2012) M. Y. Kim et al. DIABETOLOGIA
- Resveratrol Nanoparticle System Improves Dissolution Properties and Enhances the Hepatoprotective Effect of Resveratrol through Antioxidant and Anti-Inflammatory Pathways
- (2012) Chiang-Wen Lee et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction
- (2012) Chong-Shan Shi et al. NATURE IMMUNOLOGY
- Multifunctional hybrid silica nanoparticles for controlled doxorubicin loading and release with thermal and pH dual response
- (2012) Xixue Hu et al. Journal of Materials Chemistry B
- Chronic Inflammation Links Cardiovascular, Metabolic and Renal Diseases
- (2011) Ichiro Manabe CIRCULATION JOURNAL
- mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice
- (2011) Ken Inoki et al. JOURNAL OF CLINICAL INVESTIGATION
- The Inflammasomes in Kidney Disease
- (2011) H.-J. Anders et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury
- (2011) Joseph H. Holthoff et al. KIDNEY INTERNATIONAL
- Monitoring of inflammation in patients on dialysis: forewarned is forearmed
- (2011) Christiaan L. Meuwese et al. Nature Reviews Nephrology
- Tubulointerstitial injury and the progression of chronic kidney disease
- (2011) Kavita S. Hodgkins et al. PEDIATRIC NEPHROLOGY
- Pivotal Role of Toll-Like Receptors 2 and 4, Its Adaptor Molecule MyD88, and Inflammasome Complex in Experimental Tubule-Interstitial Nephritis
- (2011) Matheus Correa-Costa et al. PLoS One
- Resveratrol Attenuates Renal Hypertrophy in Early-Stage Diabetes by Activating AMPK
- (2010) Da-Fa Ding et al. AMERICAN JOURNAL OF NEPHROLOGY
- Resveratrol Inhibits Renal Fibrosis in the Obstructed Kidney
- (2010) Jinhua Li et al. AMERICAN JOURNAL OF PATHOLOGY
- Combination treatment with arsenic trioxide and irradiation enhances cell-killing effects in human fibrosarcoma cells in vitro and in vivo through induction of both autophagy and apoptosis
- (2010) Hui-Wen Chiu et al. Autophagy
- The Inflammasomes
- (2010) Kate Schroder et al. CELL
- The NLRP3 Inflammasome Promotes Renal Inflammation and Contributes to CKD
- (2010) A. Vilaysane et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cutting Edge: NF- B Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
- (2009) F. G. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives
- (2008) Joydeb Kumar Kundu et al. CANCER LETTERS
- Kidney injury molecule–1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells
- (2008) Takaharu Ichimura et al. JOURNAL OF CLINICAL INVESTIGATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search